Press release
Cancer Biomarkers Market Size, Share, Growth Insights and Report 2024-2031 | Illumina Inc, Bio-Rad Laboratories Inc, bioMérieux SA
DataM Intelligence
Will the Cancer Biomarkers Market become the sector's next big opportunity? To find out, delve into the analysis and projections for Cancer Biomarkers Market. This market research study offers in-depth insights into the opportunities, challenges, and trends currently shaping the machinery landscape, enabling industry participants to make informed decisions in a dynamic environment. Take advantage of the opportunity in the Cancer Biomarkers Market! (2031)
Global Cancer Biomarker Market reached USD 13.2 billion in 2022 and is expected to witness lucrative growth by reaching up to USD 32.5 billion by 2031. The global cancer biomarker market is expected to exhibit a CAGR of 12.3% during the forecast period (2024-2031)
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/cancer-biomarkers-market
Cancer biomarkers are biological molecules or characteristics that indicate the presence, progression, or response to treatment of cancer in the body. These biomarkers can be detected in blood, other bodily fluids, or tissues and serve various purposes, including diagnosis, prognosis, and monitoring treatment efficacy. They encompass a range of substances, such as tumor markers (like prostate-specific antigen for prostate cancer), genetic mutations (such as BRCA1 and BRCA2 mutations linked to breast and ovarian cancers), epigenetic changes that affect gene expression, and circulating tumor cells (CTCs) that indicate metastasis. The use of cancer biomarkers is crucial in personalized medicine, enabling targeted treatment strategies and improving early detection and monitoring, ultimately leading to better patient outcomes.
Key Growth Drivers in Cancer Biomarkers Market:
An increase in strategic developments is expected to drive demand in the global cancer biomarker market. Pharmaceutical corporations, diagnostic laboratories, and biotechnology firms are engaging in various strategic initiatives such as mergers, acquisitions, collaborations, partnerships, product launches, and research agreements to improve their market position and foster innovation in cancer biomarker technologies.
For instance, in March 2022, Vela Diagnostics launched advanced next-generation sequencing (NGS) panels designed for detecting both RNA and DNA cancer biomarkers in formalin-fixed paraffin-embedded (FFPE) tissue samples. The OncoKey SL 60 Plus Panel and the OncoKey SL 525 Plus Panel provide a comprehensive solution for pan-cancer analysis, detecting a wide range of genetic variations, including insertions/deletions (INDELs), copy number variations (CNVs), single nucleotide variations (SNVs), fusions, splice variants, microsatellite instability (MSI), and oncogenic viruses and bacteria.
These strategic innovations are expected to drive growth in the cancer biomarker market by improving diagnostic capabilities and offering more precise, targeted therapies. Additionally, increasing approvals for advanced diagnostic tools and personalized treatments will further fuel market demand, positioning cancer biomarkers as a key element in the future of oncology care.
DataM Intelligence profiles some of the most reputed organizations present in the Cancer Biomarkers market. They are as follows: F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., QIAGEN N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, bioMérieux SA, Enzo Biochem, Inc., Merck Millipore, Micron Technology,
Segment Covered in the Cancer Biomarkers Market:
by Cancer Indication (Sarcoma, Colorectal Cancer, Cervical Cancer, Lung Cancer, Breast Cancer)
by Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Others)
By Profiling Technology (Omics Technologies, Cytogenetics, Immunoassays, Imaging Technologies, Bioinformatics)
by Application (Drug Discovery And Development, Disease Screening and Diagnosis, Treatment Planning & Risk Assessment, Others)
Regional Analysis:
The global Cancer Biomarkers Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
Key Developments
On April 25, 2023, Guardant Health, Inc., a leading precision oncology company, and the Parker Institute for Cancer Immunotherapy (PICI), a network with the world's highest concentration of immuno-oncology (IO) expertise, announced a research collaboration agreement to study the relationship between molecular cancer biomarkers and patient response to immunotherapy treatment across more than 14 different types of cancer.
On November 24, 2022, OncoDNA, a precision medicine company specialising in the treatment of cancer and genetic diseases, and Eli Lilly Italia, a health care company delivering life-changing medicines, have announced a partnership to facilitate access to biomarker testing and support the selection of the best treatment for thyroid cancer patients in Italy.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=cancer-biomarkers-market
Regional Analysis:
The global Cancer Biomarkers Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Cancer Biomarkers Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Points Covered:
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Cancer Biomarkers market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Cancer Biomarkers Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The global Cancer Biomarkers market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Cancer Biomarkers Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/cancer-biomarkers-market
FAQ's
Q.1. What are the primary drivers of the Cancer Biomarkers Industry?
Q.2. What are the main factors propelling and impeding the growth of the Cancer Biomarkers market?
Q.3. What are the general structure, risks, and opportunities of the market?
Q.4. How do the prices, revenue, and sales of the leading Cancer Biomarkers market firms compare?
Q.5. What are the main segments of the market and how is it divided up?
Q.6. Which companies dominate the market, and what percentage of the market do they control?
Q.7. What trends are influencing the Cancer Biomarkers market now and in the future?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market Size, Share, Growth Insights and Report 2024-2031 | Illumina Inc, Bio-Rad Laboratories Inc, bioMérieux SA here
News-ID: 3696163 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Antioxidants Market Is Booming By Vita Foods 2026: Top Companies - Kaneka Medica …
DataM Intelligence has published a new research report on "Antioxidants Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Antioxidants Market Size reached US$ 5.34 billion in 2024…
Global Krill for Pet Food Market Trends & Industry Insights 2025 | Major Compani …
Global Krill for Pet Food Market reached US$ 410.2 million in 2022 and is expected to reach US$ 1,001.2 million by 2031, growing with a CAGR of 11.8% during the forecast period 2024-2031.
The Krill for Pet Food Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple…
Herbal Supplements Market 2025: Global Trends, Opportunities & Vita Foods 2026 - …
DataM Intelligence has published a new research report on "Herbal Supplements Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report (Get…
Future of Animal Parasiticides Market: Sustainable and Effective Parasite Contro …
Global Animal Parasiticides market reached US$ 11.8 billion in 2022 and is expected to reach US$ 19.09 billion by 2031, growing with a CAGR of 6.2% during the forecast period 2024-2031.
The Animal Parasiticides Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their innovative…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
